Pharma & Biotech News #PharmaBuzz
Gilead buys Arcellx for US$ 7.8 billion; FDA approves Vanda's antipsychotic pill for bipolar disorder, schizophrenia
Impressions : 411
FDA agrees to review Moderna's amended mRNA-based flu vaccine application; Lilly builds orforglipron stock ahead of approval
Impressions : 1450
FDA refuses to review Moderna's mRNA-based flu vaccine application; Lilly buys Orna for up to US$ 2.4 billion
Impressions : 1467
Fourrts' Generics Pregabalin Receives Approval in US
24 Feb 2026 //
FDA
Natco Pharma's Generics Idelalisib Receives Approval in US
17 Feb 2026 //
FDA
Zydus Pharms' Generics Bosentan Receives Approval in US
17 Feb 2026 //
FDA
Micro's Generics Colchicine Receives Approval in US
17 Feb 2026 //
FDA
Janssen's Biologics Rybrevant Faspro Receives Approval in US
13 Feb 2026 //
FDA
Avyxa's Avopef Receives Approval in US
13 Feb 2026 //
FDA
Zydus's Generics Metronidazole Receives Approval in US
13 Feb 2026 //
FDA
Macleods Pharms' Generics Colchicine Receives Approval in US
13 Feb 2026 //
FDA
West-Ward Pharms's Generics Tapentadol Receives Approval in US
13 Feb 2026 //
FDA
Zydus's Generics Ammonium Lactate Receives Approval in US
12 Feb 2026 //
FDA
A. Nelson & Co.'s Receives FDA Warning Letter
24 Feb 2026 //
FDA
Bertrand P Cole's Receives FDA Warning Letter
17 Feb 2026 //
FDA
Cosmetic Manufacturers's Receives FDA Warning Letter
17 Feb 2026 //
FDA
Conceive Fertility Center's Receives FDA Warning Letter
10 Feb 2026 //
FDA
Boothwyn Pharmacy's Receives FDA Warning Letter
10 Feb 2026 //
FDA
Signature Formulations' Receives FDA Warning Letter
10 Feb 2026 //
FDA
Bio Medical Manufacturing's Receives FDA Warning Letter
10 Feb 2026 //
FDA
Mark S Dacey's Receives FDA Warning Letter
10 Feb 2026 //
FDA
Central Coast Multispecialty's Receives FDA Warning Letter
10 Feb 2026 //
FDA
ProDx Health's Receives FDA Warning Letter
10 Feb 2026 //
FDA
Abbott Signs Pact With Novo Nordisk To Offer Semaglutide
28 Feb 2026 //
ECONOMICTIMES
Padcev-Keytruda Combo Wins in MIBC Amid Evolving Landscape
28 Feb 2026 //
FIERCE PHARMA
FDA Approves Once-Weekly YUVIWEL for Children with Achondroplasia
28 Feb 2026 //
GLOBENEWSWIRE
FDA approves Novo's Sogroya as the first and only FDA Approval
28 Feb 2026 //
PR NEWSWIRE
EU Backs Approval for Moderna's combined COVID and flu Vaccines
28 Feb 2026 //
REUTERS
Study: Half of Americans Unaware of Home Colorectal Screening
27 Feb 2026 //
GLOBENEWSWIRE
Makary Upholds FDA's Rare Disease Rejection Decisions
27 Feb 2026 //
BIOSPACE
XTL To Request Nasdaq Hearing After Delist Determination
27 Feb 2026 //
GLOBENEWSWIRE
Median Technologies To Present At TD Cowen Health Care Conference
27 Feb 2026 //
BUSINESSWIRE
FDA's TAP 2.0 Program Raises Concern In Medical Device Industry
27 Feb 2026 //
RAPS
Abbott Signs Pact With Novo Nordisk To Offer Semaglutide
28 Feb 2026 //
ECONOMICTIMES
PharmaGiant Expands Access To Affordable Medications
27 Feb 2026 //
PR NEWSWIRE
MSN Labs Expands Metabolic Care In India With CDSCO Approval
27 Feb 2026 //
PHARMABIZ
Glenmark to Launch Generic Sodium Phosphates Injection in US
27 Feb 2026 //
BUSINESS STD
Cipla Strengthens US Portfolio with The Launch of Generic Saxenda
27 Feb 2026 //
PR NEWSWIRE
Top US Lawyer Urges SCOTUS To Toss Amarin 's Label' Case
27 Feb 2026 //
FIERCE PHARMA
Alembic receives USFDA approval for Lamotrigine Orally tablets
27 Feb 2026 //
EXPRESS PHARMA
Zydus to launch generic semaglutide injections in India
25 Feb 2026 //
ECONOMICTIMES
Semaglutide Patent Expiry Slashes India's Weight-Loss Drug Prices
25 Feb 2026 //
ECONOMICTIMES
Indoco Remedies Secures USFDA ANDA for Brivaracetam Oral Solution
25 Feb 2026 //
INDPHARMAPOST
Padcev-Keytruda Combo Wins in MIBC Amid Evolving Landscape
28 Feb 2026 //
FIERCE PHARMA
EU Backs Approval for Moderna's combined COVID and flu Vaccines
28 Feb 2026 //
REUTERS
XTL To Request Nasdaq Hearing After Delist Determination
27 Feb 2026 //
GLOBENEWSWIRE
Tuhura Bio Restores Nasdaq Bid Price Compliance Requirement
27 Feb 2026 //
PR NEWSWIRE
IDEAYA Bio Announces Inducement Grants Under Nasdaq LR 5635(C)(4)
27 Feb 2026 //
PR NEWSWIRE
Asahi Kasei to buy Germany's Aicuris for $920M
27 Feb 2026 //
FIERCE BIOTECH
FDA Approves Hernexeos, the First Targeted Therapy for Adults
27 Feb 2026 //
GLOBENEWSWIRE
BMS' ADC Hits Primary Endpoints In Phase 3 Breast Cancer Trial
27 Feb 2026 //
FIERCE BIOTECH
Novo, Vivtex in up to US$2.1 bn Obesity Deal
27 Feb 2026 //
GLOBENEWSWIRE
Gilead experimental HIV treatment shows Low discontinuation rate
26 Feb 2026 //
REUTERS
AbbVie Earmarks $380M for 2 new API plants
24 Feb 2026 //
PRESS RELEASE
DoP Re-opens Online Submission For PLI Scheme For 2 Bulk Drugs
23 Feb 2026 //
PHARMABIZ
Aurobindo Pharma To Increase Pen-G Production Capacity To 10K MT
22 Feb 2026 //
BUSINESS STD
Maharashtra Sets Up 201 Bulk Drug Units in Konkan in 10 Years
18 Feb 2026 //
PHARMABIZ
Procurement Lessons From India's Pharma Sector
13 Feb 2026 //
EXPRESSPHARMA
Fresenius, Phlow Link Up To Boost US Epinephrine Injection Supply
09 Feb 2026 //
PRESS RELEASE
Lalitpur Bulk Drugs Park In UP Commences Phase-I With Approved
09 Feb 2026 //
PHARMABIZ
Sun Pharma To Pump In Rs 500 Cr In Assam Manufacturing Unit
06 Feb 2026 //
ECONOMICTIMES
Bdmai Launches E-Marketing Portal For Indian Pharma Expansion
06 Feb 2026 //
PHARMABIZ
Fis Successfully Completes €770 Million Bond Issuance
05 Feb 2026 //
PR NEWSWIRE
Drug Industry Groups And Combo Products Seek Clarity
25 Feb 2026 //
RAPS
FDA Intensifies Enforcement Against Non-Compliant Cough Syrup
24 Feb 2026 //
ECONOMICTIMES
Telangana's DCA Conducts Consecutive Raids Against Illegal Drug
24 Feb 2026 //
PHARMABIZ
Supreme Court Seeks Centre's Response On Micro Labs' Plea
24 Feb 2026 //
ECONOMICTIMES
FDA Freezes Enrollment In Macrogenics Cancer Trial After Death
24 Feb 2026 //
FIERCE BIOTECH
India Inspects 90% of Cough Syrup Makers
24 Feb 2026 //
ECONOMICTIMES
Health Ministry Notifies Several Amendments To D&C Rules, 1945
23 Feb 2026 //
PHARMABIZ
CDSCO Eases NOC Norms For Clinical Research Acceleration
23 Feb 2026 //
BUSINESS STD
Industry clamors for clearer guidance on transition to ICH M4Q
23 Feb 2026 //
RAPS
Pondicherry Health Department Issues Safety Update
23 Feb 2026 //
PHARMABIZ
Study: Half of Americans Unaware of Home Colorectal Screening
27 Feb 2026 //
GLOBENEWSWIRE
Median Technologies To Present At TD Cowen Health Care Conference
27 Feb 2026 //
BUSINESSWIRE
FDA's TAP 2.0 Program Raises Concern In Medical Device Industry
27 Feb 2026 //
RAPS
Thermo Fisher Unveils Test For Dosing Of Antirejection Drug
27 Feb 2026 //
FIERCE BIOTECH
Telix, Essen Partner on AI-Enhanced PROMISE-PET Study
27 Feb 2026 //
GLOBENEWSWIRE
Novartis Receives Positive CHMP Opinion for Remibrutinib in CSU
27 Feb 2026 //
GLOBENEWSWIRE
Lilly Debuts Nvidia Supercomputer With Fanfare And Focus
27 Feb 2026 //
FIERCE PHARMA
Ashtonmanual.org Launches As Key Benzodiazepine Tapering Resource
27 Feb 2026 //
GLOBENEWSWIRE
ARPA-H Designates Up To $144M For Anti-Aging Medical Research
25 Feb 2026 //
FIERCE BIOTECH
Treace Highlights Innovations, Data at 2026 ACFAS Meeting
24 Feb 2026 //
GLOBENEWSWIRE
FDA Approves Once-Weekly YUVIWEL for Children with Achondroplasia
28 Feb 2026 //
GLOBENEWSWIRE
FDA approves Novo's Sogroya as the first and only FDA Approval
28 Feb 2026 //
PR NEWSWIRE
Makary Upholds FDA's Rare Disease Rejection Decisions
27 Feb 2026 //
BIOSPACE
EMA CHMP Backs X4's Mavorixafor Approval for EU WHIM Syndrome
27 Feb 2026 //
GLOBENEWSWIRE
Rare Groups Push for Speed as Makary Defends Strict Stance
27 Feb 2026 //
BIOSPACE
Santhera Proposes AGAMREE® Inclusion In Spain's Health System
27 Feb 2026 //
GLOBENEWSWIRE
Illumina Accelerates Rare Disease Testing In Florida
27 Feb 2026 //
PR NEWSWIRE
FDA Approves Biomarin's PALYNZIQ For Adolescents With PKU
27 Feb 2026 //
PR NEWSWIRE
FDA Approve Once-Weekly Yuviwel for Children Aged 2 Years & Older
27 Feb 2026 //
GLOBENEWSWIRE
Aardvark Voluntary Pauses HERO Trial in Prader-Willi Syndrome
27 Feb 2026 //
GLOBENEWSWIRE
Lupin Gets US FDA EIR For Goa Facility With VAI Status
27 Feb 2026 //
PRESS RELEASE
IP Alliance's 11th GPQS 2026 Concludes with Discussions on Issues
27 Feb 2026 //
PHARMABIZ
Guardant Health Awards Inducement Grants Under Nasdaq Rule
27 Feb 2026 //
BUSINESSWIRE
Femasys Reveals Inducement Grants Per Nasdaq LR 5635(C)(4)
27 Feb 2026 //
GLOBENEWSWIRE
Caredx Reveals Inducement Grants Per Nasdaq LR 5635(C)(4)
27 Feb 2026 //
BUSINESSWIRE
ANI Pharma Reports Strong Q4 2025 Results, Reaffirm 2026 Guidance
27 Feb 2026 //
GLOBENEWSWIRE
US FDA to Offer Bonuses To Staff For Faster Drug Reviews
27 Feb 2026 //
REUTERS
Bayer Secures India Approval For Expanded Use Of Nubeqa
27 Feb 2026 //
EXPRESSPHARMA
Lupin CEO, Vinita Gupta Honored On 2026 CNBC Changemakers List
27 Feb 2026 //
PR NEWSWIRE
Apyx Medical to Release Q4 FY2025 Results on March 10
25 Feb 2026 //
GLOBENEWSWIRE

Market Place
Sourcing Support